Cargando…

Development and validation of an LC-MS/MS method for detection and quantification of in vivo derived metabolites of [Pyr(1)]apelin-13 in humans

[Pyr(1)]apelin-13 is the predominant apelin peptide isoform in the human cardiovascular system and plasma. To date, few studies have investigated [Pyr(1)]apelin-13 metabolism in vivo in rats with no studies examining its stability in humans. We therefore aimed to develop an LC-MS/MS method for detec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nyimanu, Duuamene, Kay, Richard G., Sulentic, Petra, Kuc, Rhoda E., Ambery, Philip, Jermutus, Lutz, Reimann, Frank, Gribble, Fiona M., Cheriyan, Joseph, Maguire, Janet J., Davenport, Anthony P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6934825/ https://www.ncbi.nlm.nih.gov/pubmed/31882594 http://dx.doi.org/10.1038/s41598-019-56157-9

Ejemplares similares

Apelin-36-[L28A] and Apelin-36-[L28C(30kDa-PEG)] peptides that improve diet induced obesity are G protein biased ligands at the apelin receptor
por: Nyimanu, Duuamene, et al.
Publicado: (2019)

[Pyr(1)]Apelin-13((1–12)) Is a Biologically Active ACE2 Metabolite of the Endogenous Cardiovascular Peptide [Pyr(1)]Apelin-13
por: Yang, Peiran, et al.
Publicado: (2017)

In vitro metabolism of synthetic Elabela/Toddler (ELA-32) peptide in human plasma and kidney homogenates analyzed with mass spectrometry and validation of endogenous peptide quantification in tissues by ELISA
por: Nyimanu, Duuamene, et al.
Publicado: (2021)

The therapeutic potential of apelin in kidney disease
por: Chapman, Fiona A., et al.
Publicado: (2021)

Apelin is expressed throughout the human kidney, is elevated in chronic kidney disease & associates independently with decline in kidney function
por: Nyimanu, Duuamene, et al.
Publicado: (2022)

Plasma levels of apelin are reduced in patients with liver fibrosis and cirrhosis but are not correlated with circulating levels of bone morphogenetic protein 9 and 10
por: Owen, Nicola E., et al.
Publicado: (2021)

The G Protein Biased Small Molecule Apelin Agonist CMF-019 is Disease Modifying in Endothelial Cell Apoptosis In Vitro and Induces Vasodilatation Without Desensitisation In Vivo
por: Read, Cai, et al.
Publicado: (2021)

International Union of Basic and Clinical Pharmacology. CVII. Structure and Pharmacology of the Apelin Receptor with a Recommendation that Elabela/Toddler Is a Second Endogenous Peptide Ligand
por: Read, Cai, et al.
Publicado: (2019)

Trans-myocardial Extraction of Endothelin-1 Correlates with Increased Microcirculatory Resistance following Percutaneous Coronary Intervention
por: Abraham, George R., et al.
Publicado: (2022)

A novel cyclic biased agonist of the apelin receptor, MM07, is disease modifying in the rat monocrotaline model of pulmonary arterial hypertension
por: Yang, Peiran, et al.
Publicado: (2019)

Organoid Sample Preparation and Extraction for LC-MS Peptidomics
por: Miedzybrodzka, Emily L., et al.
Publicado: (2020)

LC-MS/MS based detection of circulating proinsulin derived peptides in patients with altered pancreatic beta cell function
por: Foreman, Rachel E, et al.
Publicado: (2022)

Optimized LC-MS/MS Method for the Detection of ppCCK(21–44): A Surrogate to Monitor Human Cholecystokinin Secretion
por: Foreman, Rachel E., et al.
Publicado: (2023)

Stoichiometric Quantification of Akt Phosphorylation Using LC-MS/MS
por: Atrih, Abdelmadjid, et al.
Publicado: (2009)

Pipelines and Systems for Threshold-Avoiding Quantification of LC–MS/MS Data
por: Sánchez Brotons, Alejandro, et al.
Publicado: (2021)

Estimation of measurement uncertainty for the quantification of protein by ID-LC–MS/MS
por: Beasley-Green, Ashley, et al.
Publicado: (2023)

Differential expression in humans of the viral entry receptor ACE2 compared with the short deltaACE2 isoform lacking SARS-CoV-2 binding sites
por: Williams, Thomas L., et al.
Publicado: (2021)

Quantification of cGMP in human plasma by isotope dilution LC-MS/MS
por: Martens-Lobenhoffer, Jens, et al.
Publicado: (2009)

LC-MS/MS Quantification of Tramadol and Gabapentin Utilizing Solid Phase Extraction
por: Nagaraju, Pappula, et al.
Publicado: (2018)

Fast and Simple LC-MS/MS Method for Rifampicin Quantification in Human Plasma
por: Temova Rakuša, Žane, et al.
Publicado: (2019)

Modern Approaches in the Identification and Quantification of Immunogenic Peptides in Cereals by LC-MS/MS
por: Alves, Thais O., et al.
Publicado: (2019)

LC-MS/MS for Ultra-Sensitive Quantification of Multiple Estrogens in the Blood and Brain
por: Jalabert, Cecilia, et al.
Publicado: (2021)

Rapid LC-MS/MS Bosutinib Quantification with Applications in Metabolic Stability Estimation
por: Attwa, Mohamed W., et al.
Publicado: (2023)

Development, Validation, and Comparison of Two Mass Spectrometry Methods (LC-MS/HRMS and LC-MS/MS) for the Quantification of Rituximab in Human Plasma
por: Millet, Aurélien, et al.
Publicado: (2021)

Expanding the apelin receptor pharmacological toolbox using novel fluorescent ligands
por: Williams, Thomas L., et al.
Publicado: (2023)

Development and validation of a LC–MS/MS method for quantification of hetrombopag for pharmacokinetics study
por: Chen, Tao, et al.
Publicado: (2015)

Validated LC-MS/MS Method for the Quantification of Ponatinib in Plasma: Application to Metabolic Stability
por: Kadi, Adnan A., et al.
Publicado: (2016)

Quantification of tolvaptan in rabbit plasma by LC–MS/MS: Application to a pharmacokinetic study()
por: Moola, Kumar S., et al.
Publicado: (2015)

Identification and Quantification of Enniatins and Beauvericin in Animal Feeds and Their Ingredients by LC-QTRAP/MS/MS
por: Tolosa, Josefa, et al.
Publicado: (2019)

New method for quantification of gasotransmitter hydrogen sulfide in biological matrices by LC-MS/MS
por: Tan, Bo, et al.
Publicado: (2017)

A Simple LC-MS/MS Method for the Quantification of PDA-66 in Human Plasma
por: Schwarz, Rico, et al.
Publicado: (2022)

Investigation of the metabolic stability of olmutinib by validated LC-MS/MS: quantification in human plasma
por: Attwa, Mohamed W., et al.
Publicado: (2018)

Multiplexed quantification of insulin and C-peptide by LC-MS/MS without the use of antibodies
por: Foulon, North, et al.
Publicado: (2022)

Ultrasensitive Quantification of Multiple Estrogens in Songbird Blood and Microdissected Brain by LC-MS/MS
por: Jalabert, Cecilia, et al.
Publicado: (2022)

Development and validation of an LC–MS/MS method for the quantification of artificial sweeteners in human matrices
por: Greibe, Eva, et al.
Publicado: (2022)

A multi-analyte LC-MS/MS method for screening and quantification of nitrosamines in sartans
por: Chang, Shu-Han, et al.
Publicado: (2020)

Simultaneous quantification of nirmatrelvir and ritonavir by LC-MS/MS in patients treated for COVID-19
por: Martens-Lobenhoffer, Jens, et al.
Publicado: (2022)

Quantification and reporting of vitamin D concentrations measured in human milk by LC–MS/MS
por: Jones, Kerry S., et al.
Publicado: (2023)

Identification and quantification of mepirapim and acetyl fentanyl in authentic human whole blood and urine samples by GC–MS/MS and LC–MS/MS
por: Mochizuki, Akira, et al.
Publicado: (2017)

LC, MS(n) and LC–MS/MS studies for the characterization of degradation products of amlodipine
por: Tiwari, Ravi N., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_qrlvuch9v241691ck6u9kaard3